Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

77.04
Delayed Data
As of 4:02pm ET
 -0.16 / -0.21%
Today’s Change
66.93
Today|||52-Week Range
83.58
+5.77%
Year-to-Date
ImmunoGen, Inc.: Waiting to Move FORWARD
3:41pm / MotleyFool.com - Paid Partner Content
Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
Feb 17 / TheStreet.com - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
2:12pm / MotleyFool.com - Paid Partner Content
Nexthera Capital Lp Buys Novartis AG, Celgene, Alexion Pharmaceuticals, Sells GlaxoSm...
Feb 16 / GuruFocus News - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
12:30pm / MotleyFool.com - Paid Partner Content
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Feb 19 / MotleyFool.com - Paid Partner Content
Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook
Feb 15 / Zacks.com - Paid Partner Content
2 High-Yield Dividend Stocks That Are Ridiculously Cheap
Feb 18 / MotleyFool.com - Paid Partner Content
Saturna Capital CORP Buys NXP Semiconductors NV, Under Armour, Edwards Lifesciences, ...
Feb 15 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close77.20
Today’s open76.53
Day’s range76.48 - 77.34
Volume3,897,897
Average volume (3 months)3,493,071
Market cap$179.4B
Dividend yield3.53%
Data as of 4:02pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.90%
Revenue growth (last year)-1.90%
P/E ratio27.1
Price/Sales3.61
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.09+0.14%
PFEPfizer0.000.00%
SNYSanofi-0.40-0.93%
GSKGlaxoSmithKline+0.29+0.70%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$1.17
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts


Search for Jobs